Free Brochure: Pulmonary Hypertension & Methamphetamine

People who use methamphetamine (or meth) have an increased risk of heart diseases, including diseases of the coronary arteries and the heart muscle — and lung diseases, such as acute bleeding of the lungs, excess fluid in the lungs, collapsed lungs and pulmonary arterial hypertension (PAH).

For more than 10 years, researchers have been looking for information to better understand the association of meth use and PAH. Studies have looked at persons with different types of PAH to see if there were differences in self-reported stimulant use, including meth. While these are not controlled studies, medical professionals are aware of a strong association between stimulant use and PAH. How the two are associated, however, remains unknown.

It is essential that patients are honest with their doctors about past and present drug use in order to help diagnose meth-related PAH.

Download the Pulmonary Hypertension Association (PHA)’s free patient brochure to learn more about PH risks and treatment options.

This information is part of the PHA Associated Diseases Outreach and Engagement program, supported by Janssen Pharmaceuticals.